TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT06111781: The SUGAR Study; SBRT and Relugolix) for Prostate Cancer

Sponsor: Yale University · Phase: PHASE2 · Area: ONCOLOGY · Target Enrollment: 60 pts

Competing Trials Overlap

5 Active Trials

Excess Burn Exposure

$8,685,600

Rescue Site Savings

+$5,728,800

Unlock Full NCT06111781 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT06111781 Rescue Dossier →